{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T11:05:50Z","timestamp":1773745550464,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,17]]},"DOI":"10.7759\/cureus.105361","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T10:21:49Z","timestamp":1773742909000},"source":"Crossref","is-referenced-by-count":0,"title":["From Type 2 Diabetes Mellitus to Autoimmune Failure: Euglycemic Diabetic Ketoacidosis Revealing Latent Autoimmune Diabetes in Adults"],"prefix":"10.7759","author":[{"given":"Venkata Yashashwini","family":"Maram Reddy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkata Sai rithin","family":"Maramreddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reddy Jhansi","family":"Ramireddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-020-05211-7","article-title":"The clinical consequences of heterogeneity within and between different diabetes types","volume":"63","author":"Redondo MJ","year":"2020","unstructured":"Redondo MJ, Hagopian WA, Oram R, et al.. The clinical consequences of heterogeneity within and between different diabetes types. Diabetologia. 2020, 63:2040-8. 10.1007\/s00125-020-05211-7","journal-title":"Diabetologia"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2337\/dbi20-0017","article-title":"Management of latent autoimmune diabetes in adults: a consensus statement from an international expert panel","volume":"69","author":"Buzzetti R","year":"2020","unstructured":"Buzzetti R, Tuomi T, Mauricio D, Pietropaolo M, Zhou Z, Pozzilli P, Leslie RD. Management of latent autoimmune diabetes in adults: a consensus statement from an international expert panel. Diabetes. 2020, 69:2037-47. 10.2337\/dbi20-0017","journal-title":"Diabetes"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0931","article-title":"Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: action LADA 7","volume":"36","author":"Hawa MI","year":"2013","unstructured":"Hawa MI, Kolb H, Schloot N, et al.. Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: action LADA 7. Diabetes Care. 2013, 36:908-13. 10.2337\/dc12-0931","journal-title":"Diabetes Care"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2018.0190","article-title":"Latent autoimmune diabetes in adults: a review on clinical implications and management","volume":"42","author":"Pieralice S","year":"2018","unstructured":"Pieralice S, Pozzilli P. Latent autoimmune diabetes in adults: a review on clinical implications and management. Diabetes Metab J. 2018, 42:451-64. 10.4093\/dmj.2018.0190","journal-title":"Diabetes Metab J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0281657","article-title":"Development and validation of a clinical score for identifying patients with high risk of latent autoimmune adult diabetes (LADA): the LADA primary care-protocol study","volume":"18","author":"Vich-P\u00e9rez P","year":"2023","unstructured":"Vich-P\u00e9rez P, Ab\u00e1nades-Herranz JC, Mora-Navarro G, et al.. Development and validation of a clinical score for identifying patients with high risk of latent autoimmune adult diabetes (LADA): the LADA primary care-protocol study. PLoS One. 2023, 18:e0281657. 10.1371\/journal.pone.0281657","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-1111","article-title":"A type 1 diabetes genetic risk score can aid discrimination between type 1 diabetes and type 2 diabetes in young adults","volume":"39","author":"Oram RA","year":"2016","unstructured":"Oram RA, Patel K, Hill A, et al.. A type 1 diabetes genetic risk score can aid discrimination between type 1 diabetes and type 2 diabetes in young adults. Diabetes Care. 2016, 39:337-44. 10.2337\/dc15-1111","journal-title":"Diabetes Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3480","article-title":"Innate immunity in latent autoimmune diabetes in adults","volume":"38","author":"Huang J","year":"2022","unstructured":"Huang J, Pearson JA, Wong FS, Wen L, Zhou Z. Innate immunity in latent autoimmune diabetes in adults. Diabetes Metab Res Rev. 2022, 38:e3480. 10.1002\/dmrr.3480","journal-title":"Diabetes Metab Res Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-020-02607-2","article-title":"Sodium-glucose cotransporter-2-induced euglycemic diabetic ketoacidosis unmasks latent autoimmune diabetes in a patient misdiagnosed with type\u00a02 diabetes mellitus: a case report","volume":"15","author":"Vadasz B","year":"2021","unstructured":"Vadasz B, Arazi M, Shukha Y, Koren O, Taher R. Sodium-glucose cotransporter-2-induced euglycemic diabetic ketoacidosis unmasks latent autoimmune diabetes in a patient misdiagnosed with type\u00a02 diabetes mellitus: a case report. J Med Case Rep. 2021, 15:62. 10.1186\/s13256-020-02607-2","journal-title":"J Med Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.836952","article-title":"GAD65 antibody epitopes and genetic background in latent autoimmune diabetes in youth (LADY)","volume":"13","author":"Peng Y","year":"2022","unstructured":"Peng Y, Li X, Xiang Y, et al.. GAD65 antibody epitopes and genetic background in latent autoimmune diabetes in youth (LADY). Front Immunol. 2022, 13:836952. 10.3389\/fimmu.2022.836952","journal-title":"Front Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12834","article-title":"Altered regulatory T cell phenotype in latent autoimmune diabetes of the adults (LADA)","volume":"186","author":"Radenkovic M","year":"2016","unstructured":"Radenkovic M, Silver C, Arvastsson J, et al.. Altered regulatory T cell phenotype in latent autoimmune diabetes of the adults (LADA). Clin Exp Immunol. 2016, 186:46-56. 10.1111\/cei.12834","journal-title":"Clin Exp Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-1765","article-title":"Altered peripheral B-lymphocyte subsets in type 1 diabetes and latent autoimmune diabetes in adults","volume":"39","author":"Deng C","year":"2016","unstructured":"Deng C, Xiang Y, Tan T, et al.. Altered peripheral B-lymphocyte subsets in type 1 diabetes and latent autoimmune diabetes in adults. Diabetes Care. 2016, 39:434-40. 10.2337\/dc15-1765","journal-title":"Diabetes Care"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.199050","article-title":"Single-cell immune transcriptomics reveals an inflammatory-inhibitory set-point spectrum in autoimmune diabetes","volume":"11","author":"Golodnikov II","year":"2026","unstructured":"Golodnikov II, Podshivalova ES, Chechekhin VI, et al.. Single-cell immune transcriptomics reveals an inflammatory-inhibitory set-point spectrum in autoimmune diabetes. JCI Insight. 2026, 11:e199050. 10.1172\/jci.insight.199050","journal-title":"JCI Insight"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf001","article-title":"IFN-\u03b1 neutralizing antibodies distinguish Lada from early-onset type 1 diabetes","volume":"110","author":"Amendolara R","year":"2025","unstructured":"Amendolara R, D'Onofrio L, Sessa RL, et al.. IFN-\u03b1 neutralizing antibodies distinguish Lada from early-onset type 1 diabetes. J Clin Endocrinol Metab. 2025, 110:2565-72. 10.1210\/clinem\/dgaf001","journal-title":"J Clin Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00183","article-title":"Interaction between overweight and genotypes of HLA, TCF7L2, and FTO in relation to the risk of latent autoimmune diabetes in adults and type 2 diabetes","volume":"104","author":"Hjort R","year":"2019","unstructured":"Hjort R, L\u00f6fvenborg JE, Ahlqvist E, et al.. Interaction between overweight and genotypes of HLA, TCF7L2, and FTO in relation to the risk of latent autoimmune diabetes in adults and type 2 diabetes. J Clin Endocrinol Metab. 2019, 104:4815-26. 10.1210\/jc.2019-00183","journal-title":"J Clin Endocrinol Metab"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-022-05725-2","article-title":"Birthweight, BMI in adulthood and latent autoimmune diabetes in adults: a Mendelian randomisation study","volume":"65","author":"Wei Y","year":"2022","unstructured":"Wei Y, Zhan Y, L\u00f6fvenborg JE, Tuomi T, Carlsson S. Birthweight, BMI in adulthood and latent autoimmune diabetes in adults: a Mendelian randomisation study. Diabetologia. 2022, 65:1510-8. 10.1007\/s00125-022-05725-2","journal-title":"Diabetologia"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-0739","article-title":"All-cause mortality and cardiovascular and microvascular diseases in latent autoimmune diabetes in adults","volume":"46","author":"Wei Y","year":"2023","unstructured":"Wei Y, Herzog K, Ahlqvist E, et al.. All-cause mortality and cardiovascular and microvascular diseases in latent autoimmune diabetes in adults. Diabetes Care. 2023, 46:1857-65. 10.2337\/dc23-0739","journal-title":"Diabetes Care"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/dom.16048","article-title":"Increased cardiovascular risk in people with LADA in comparison to type 1 diabetes and type 2 diabetes: findings from the DPV registry in Germany and Austria","volume":"27","author":"Golomb RC","year":"2025","unstructured":"Golomb RC, Tittel SR, Welters A, et al.. Increased cardiovascular risk in people with LADA in comparison to type 1 diabetes and type 2 diabetes: findings from the DPV registry in Germany and Austria. Diabetes Obes Metab. 2025, 27:563-73. 10.1111\/dom.16048","journal-title":"Diabetes Obes Metab"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/470500-from-type-2-diabetes-mellitus-to-autoimmune-failure-euglycemic-diabetic-ketoacidosis-revealing-latent-autoimmune-diabetes-in-adults","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T10:21:50Z","timestamp":1773742910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/470500-from-type-2-diabetes-mellitus-to-autoimmune-failure-euglycemic-diabetic-ketoacidosis-revealing-latent-autoimmune-diabetes-in-adults"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.105361","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,17]]}}}